QLB BIOTHERAPEUTICS Trademark

Trademark Overview

On Monday, August 28, 2017, a trademark application was filed for QLB BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the QLB BIOTHERAPEUTICS trademark a serial number of 87585597. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2019. This trademark is owned by QLB Biotherapeutics, Inc.. The QLB BIOTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
qlb biotherapeutics

General Information

Serial Number87585597
Word MarkQLB BIOTHERAPEUTICS
Filing DateMonday, August 28, 2017
Status700 - REGISTERED
Status DateTuesday, July 30, 2019
Registration Number5822386
Registration DateTuesday, July 30, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Description of MarkThe mark consists of three intersecting ovals appearing in an atomic model molecular design resembling the three domains of an antibody molecule, with the two ovals at the top of the design appearing in blue, and with the oval at the bottom of the design appearing in red, with half of each oval appearing with a bold thick line with the other half appearing as a thin line. To the right of the design is the wording "QLB BIOTHERAPEUTICS" appearing in black with the letters "QLB" appearing centered over the word "BIOTHERAPEUTICS". The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Indication of Colors claimedThe color(s) Black, Red and Blue are claimed as a feature of the mark.
NOT AVAILABLE"BIOTHERAPEUTICS"
Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 1, 2017
Primary Code042
First Use Anywhere DateSunday, October 16, 2016
First Use In Commerce DateThursday, March 1, 2018

Trademark Owner History

Party NameQLB Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameQLB Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameQLB Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Trademark Events

Event DateEvent Description
Saturday, September 2, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 31, 2017NEW APPLICATION ENTERED
Friday, September 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 3, 2017ASSIGNED TO EXAMINER
Wednesday, December 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 12, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 19, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 19, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, December 19, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 19, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, December 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 5, 2018ASSIGNED TO LIE
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 10, 2018SOU EXTENSION 1 FILED
Tuesday, October 16, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, October 16, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 16, 2018PETITION TO REVIVE-GRANTED
Tuesday, October 16, 2018SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, October 16, 2018USE AMENDMENT FILED
Wednesday, October 17, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, January 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 3, 2019SOU EXTENSION 1 GRANTED
Thursday, January 3, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, January 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 24, 2019SU - NON-FINAL ACTION - WRITTEN
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 24, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

biotherapeutics development products pharmaceutical